306
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Relationship of Plasma Gremlin 1 Levels with Body Adiposity and Glycemic Control in Saudi Female Type 2 Diabetes Patients

ORCID Icon, , , , , , , & show all
Pages 3429-3436 | Received 09 May 2022, Accepted 11 Oct 2022, Published online: 03 Nov 2022

References

  • Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–298. doi:10.1038/s41574-019-0176-8
  • Bragg F, Holmes MV, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA. 2017;317(3):280–289. doi:10.1001/jama.2016.19720
  • Owolabi LF, Adamu B, Imam AI, et al. Systematic review and meta-analysis estimating the prevalence, burden, and trend of diabetes mellitus in Saudi Arabia. J Diabetes Endocr Pract. 2020;3:1–8.
  • Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81–87. doi:10.1097/MED.0b013e3283514e13
  • Gustafson B, Hammarstedt A, Hedjazifar S, et al. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes. 2015;64:1670–1681. doi:10.2337/db14-1127
  • Modica S, Straub LG, Balaz M, et al. Bmp4 promotes a brown to white-like adipocyte shift. Cell Rep. 2016;16:2243–2258. doi:10.1016/j.celrep.2016.07.048
  • Yanagita M. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev. 2005;16(3):309–317. doi:10.1016/j.cytogfr.2005.02.007
  • Denton NF, Eghleilib M, Al-Sharifi S, et al. Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis. Int J Obes. 2019;43(12):2458–2468. doi:10.1038/s41366-019-0421-1
  • Hedjazifar S, Shahidi RK, Hammarstedt A, et al. The novel adipokine gremlin 1 antagonizes insulin action and is increased in type 2 diabetes and NAFLD/NASH. Diabetes. 2020;69(3):331–341. doi:10.2337/db19-0701
  • American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl1):S13–S28. doi:10.2337/dc19-S002
  • Michos O, Panman L, Vintersten K, et al. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development. 2004;131(14):3401–3410. doi:10.1242/dev.01251
  • Merino R, Rodriguez-Leon J, Macias D, et al. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development. 1999;126(23):5515–5522. doi:10.1242/dev.126.23.5515
  • Canalis E, Parker K, Zanotti S. Gremlin1 is required for skeletal development and postnatal skeletal homeostasis. J Cell Physiol. 2012;227(1):269–277. doi:10.1002/jcp.22730
  • Mezzano S, Droguett A, Lavoz C, Krall P, Egido J, Ruiz-Ortega M. Gremlin and renal diseases: ready to jump the fence to clinical utility? Nephrol Dial Transplant. 2018;33(5):735–741. doi:10.1093/ndt/gfx194
  • Al-Najeem HT, Al-Dujaili ANG. Assessment of Gremlin-1 level in pulmonary arterial hypertension disease. Research J Pharm Tech. 2017;10(11):3803–3806.
  • Habib SS, Al Regaeiy AK, Al Dokhi L. Assessment of adipokines relationships with cardiovascular risk markers in relation to body indices in normoglycemic males. Pak J Med Sci. 2013;29(1):21–26. doi:10.12669/pjms.291.2913
  • Herder C, Kannenberg JM, Niersmann C, et al. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol. 2017;177(4):277–286. doi:10.1530/EJE-17-0100
  • Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H, AlSaif S. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women. Eur Rev Med Pharmacol Sci. 2017;21(6):1296–1302. PMID: 28387898.
  • Habib SS, Sultan M, Khan A, Al-Khlaiwi T, Bashir S. Circulating adiponectin and resistin levels are associated with adiposity indices and physical fitness in healthy adult males. Med Sci Monit Basic Res. 2021;27:e930322. PMID:34158467.
  • Müller KA, Rath D, Schmid M, et al. High plasma levels of Gremlin-1 and macrophage migration inhibitory factor, but not their ratio, indicate an increased risk for acute coronary syndrome in patients with type 2 diabetes mellitus. Clin Cardiol. 2016;39(4):201–206. doi:10.1002/clc.22509
  • Afkarian M, Hirsch IB, Tuttle KR, Greenbaum C, Himmelfarb J, de Boer IH. Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease. Physiol Rep. 2014;2(5):e12010. doi:10.14814/phy2.12010
  • Roxburgh SA, Kattla JJ, Curran SP, et al. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes. 2009;58(7):1641–1650.
  • Marchant V, Droguett A, Valderrama G, et al. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy. Am J Physiol Renal Physiol. 2015;309(6):F559–F568. doi:10.1152/ajprenal.00023.2015
  • Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. doi:10.1038/nri2921
  • Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461–470. doi:10.1016/j.tips.2015.04.014
  • Habib SS, Bashir S, Habib SH. Serum visfatin relationship with glycemic control and adiposity indices in patients with type 2 diabetes mellitus. Khyber Med Univ J. 2020;12(4):263–267. doi:10.35845/kmuj.2020.20254